Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

43results about How to "Novel structure type" patented technology

Flexible microgripper through topological optimization

The invention relates to a flexible microgripper through topological optimization, which belongs to a microactuators in the technical field of the micro electro mechanical systems and is a flexible electrothermally driven microgripper. The flexible microgripper consists of a shift amplifying section and a driving section and is an integral structure with the eudipleural gripper body. The shift amplifying section M is designed by using the topological optimization method and comprises left and right triangular components and a flexible rod, wherein the left and right triangular components randomly hollow triangle structures. The driving section comprises a V-shaped beam array, left and right driving fixed rods and left and right electrodes. The microgripper has the advantages of unique and novel structure, large output shift, rapid response, simple control, convenient integration and is effective and energy-saving without applying drive in the process of gripping objects, thereby the microgripper is quite suitable for gripping minute objects for micro-assembly, micro-operation and the like.
Owner:DALIAN UNIV OF TECH

Thieno-thiopyrano pyrazole compound and pharmaceutical applications thereof

InactiveCN103980289AInhibits cyclooxygenase activityNovel structure typeOrganic active ingredientsNervous disorderDiseaseNeuralgia
The invention belongs to the field of medical technologies, and relates to a thieno-thiopyrano pyrazole compound and pharmaceutical applications thereof. The thieno-thiopyrano pyrazole compound comprises derivatives of the thieno-thiopyrano pyrazole compound and pharmaceutical applicable salts. The thieno-thiopyrano pyrazole compound and salts added by pharmaceutically applicable acids of the compound can be combined with existing drugs or used alone as a lipoxygenase inhibitor, and used for treating related diseases such as chronic dull pains including inflammations, gout, headache, toothache, neuralgia and arthralgia which are relevant to an arachidonic acid metabolizing process.
Owner:SHENYANG PHARMA UNIVERSITY

5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran derivatives and application thereof

The invention belongs to the technical field of medicines, and relates to 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran derivatives and an application thereof. The 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran derivatives comprise stereoisomers and pharmaceutically acceptable salts of 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran, and the structural formula of the derivatives is shownin the description. The 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran derivatives and the pharmaceutically acceptable acid addition formed salts of 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran can be used together with existing medicines or individually, and are used for preparing medicines for treating blood vessel smooth muscle spasm diseases.
Owner:SHENYANG PHARMA UNIVERSITY

6-methyl-thiazole triazole-5-formamide derivative and application

The invention discloses a 6-methyl-thiazole [3,2-b] [1,2,4]-triazole-5-formamide derivative as shown in formula I or pharmaceutically acceptable hydrate and salt thereof, including stereisomer or tautomer thereof. In the formula I, R1 is hydrogen, methyl, halogen, hydroxy, methoxyl, acetyl, propionyl, nitryl or alkoxy; R2 and R3 are independently selected from C1-C6 alkyl; or R2, R3 and nitrogen atoms connected with R2 and R3 form pyrrolyl, piperidyl, morpholinyl, N-methyl piperazine and N-(4-bromophenyl) piperazine. The 6-methyl-thiazole [3,2-b] [1,2,4]-triazole-5-formamide derivative disclosed by the invention is used as a vascular endothelial growth factor protein tyrosine kinase inhibitor for treating and preventing various cancers.
Owner:河北戴桥医药科技有限公司

1-Aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea compound and application thereof

The invention belongs to the technical field of medicine and relates to 1-aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea compound, a preparation method thereof and application of the compound in thepreparation of antitumor drugs. The 1-aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea compound and its prodrug, pharmaceutical active metabolite and pharmaceutically acceptable salt have a structuralgeneral formula shown in the description, wherein X is independently selected from CH and N, R may be hydrogen, C1-C4 alkyl group, halogen-substituted C1-C4 alkyl group, C1-C4 alkoxy group, halogen-substituted C1-C4 alkoxy group, and halogen, R may be single or multiple, R3, R4 and R5 are independently selected from hydrogen, C1-C4 alkyl group, C1-C4 alkoxy group, halogen-substituted C1-C4 alkoxygroup, and C1-C4 alkoxy-substituted C1-C4 alkoxy group. The synthetic method of the compound of the invention is simple and is suitable for industrial production; bioactivity test shows that the compound of the invention has antitumor activity and is a novel antitumor drug.
Owner:SHENYANG PHARMA UNIVERSITY

7H-benzo-isoxazole-[7,6-e][1,3]oxazine derivatives and application

The invention discloses 7H-benzo-isoxazole-[7,6-e][1,3]oxazine derivatives as shown in the formula I or pharmaceutically acceptable hydrates / salts thereof, and further discloses stereoisomers or tautomers of the 7H-benzo-isoxazole-[7,6-e][1,3]oxazine derivatives. According to the formula I, R1 represents a hydrogen group, a methyl group, an ethyl group, a halogen group, a methoxyl group, an ethoxy group, a nitro group or an alkoxyl group. The 7H-benzo-isoxazole-[7,6-e][1,3]oxazine derivatives have an obvious effect in inhibiting acetyl cholinesterase, and can be used for enhancing the memory of patients suffering from dementia and the Alzheimer's disease. The invention further relates to preparation methods of the derivatives and application of the derivatives to preparation of medicine used for treating the Alzheimer's disease.
Owner:SHIJIAZHUANG UNIVERSITY

1-aryl-3-[4-(pyridine-2-ylmethoxy) phenyl urea compound and application

The invention belongs to the technical field of medicines and relates to a 1-aryl-3-[4-(pyridine-2-ylmethoxy) phenyl urea compound as well as a preparation method and the application thereof in preparing medicines for treating tumor diseases. The 1-aryl-3-[4-(pyridine-2-ylmethoxy) phenyl urea compound, a predrug, a medicine active metabolite and a pharmaceutically acceptable salt thereof have structural formulae as shown in the specification, in the formulae, R is one or more of hydrogen, C1-C4 alkyl, halogen-substituted C1-C4 alkyl, C1-C4 alkoxy, halogen-substituted C1-C4 alkoxy and halogen;and R1, R4 and R5 can be independently selected from hydrogen, C1-C4 alkyl, C1-C4 alkoxy, halogen-substituted C1-C4 alkoxy and C1-C4 C1-C4 alkoxy substituted C1-C4 C1-C4 alkoxy. The compound providedby the invention is simple and convenient in synthesis method and applicable to industrial production, and biological activity tests show that the compound has anti-tumor activity and is a type of novel anti-tumor medicines.
Owner:SHENYANG PHARMA UNIVERSITY

Application of hederagenin polyethylene glycol derivative

ActiveCN112076200AImprove water solubilityExcellent tumor resistance reversal activityOrganic active ingredientsSteroidsLung cancerColonic Cancers
The invention discloses application of a hederagenin polyethylene glycol derivative. Specifically, the invention discloses application of the hederagenin polyethylene glycol derivative in preparationof a tumor drug resistance reversal agent. The hederagenin polyethylene glycol derivative with a novel structure type provided by the invention has improved water solubility and excellent tumor drug resistance reversal activity. The hederagenin polyethylene glycol derivative and a pharmaceutically acceptable carrier are used for treating diseases or symptoms such as oral epithelial cancer, gastriccancer, lung cancer, cervical cancer, breast cancer or colon cancer together with clinically common antitumor drugs. The hederagenin polyethylene glycol derivative and the medically acceptable salt thereof are used for preparing the tumor drug resistance reversal agent and / or the pharmaceutically acceptable carrier for treating mammals, preferably human diseases or symptoms.
Owner:YANTAI UNIV

6-[2-hydroxyl-3-(alkylamino)propoxy]benzofuran compound and application thereof

The invention belongs to the technical field of medicines and relates to a 6-[2-hydroxyl-3-(alkylamino)propoxy]benzofuran compound and an application thereof. The 6-[2-hydroxyl-3-(alkylamino)propoxy]benzofuran compound comprises a stereoisomer and pharmacologically applicable salt of the compound and has the general structural formula shown in the description, wherein R is shown in the claims andspecification. The 6-[2-hydroxyl-3-(alkylamino)propoxy]benzofuran compound and the pharmacologically applicable salt-additive salt of the compound can be mixed with an existing medicine for use or used alone to be applied to a medicine for treating spastic diseases of vascular smooth muscle.
Owner:SHENYANG PHARMA UNIVERSITY

5-[2-hydroxy-3-(alkylamine) propoxy] benzofuran compound and application thereof

The invention belongs to the technical field of medicines and relates to a 5-[2-hydroxy-3-(alkylamine) propoxy] benzofuran compound and the application thereof. The 5-[2-hydroxy-3-(alkylamine) propoxy] benzofuran compound comprises a stereisomer of the compound and pharmaceutically applicable salt; the general molecular formula of the compound is shown as follows: wherein R is described as the claims and the specification. The 5-[2-hydroxy-3-(alkylamine) propoxy] benzofuran compound and the pharmaceutically applicable acid addition salt of the compound can be combined with the existing drug for use or can be used alone, and are used for preparing a drug for treating a vascular smooth muscle spastic disease.
Owner:SHENYANG PHARMA UNIVERSITY

5H-[1, 2, 4] triazole [5, 1-b] [1, 3] thiazide derivative and application

The invention discloses a 5H-[1, 2, 4] triazole [5, 1-b] [1, 3] thiazide derivative with a general formula I, or a pharmaceutically acceptable aquo-complex and salts of the derivative; the derivative comprises a stereisomer or a tautomer, wherein R1 and R2 in the formula I are respectively independent hydrogen, methyl, halogen, hydroxyl, methoxyl, acetyl, propiono, nitro or alkoxy. The 5H-[1, 2, 4] triazole [5, 1-b] [1, 3] thiazide derivative has an obvious inhibiting effect on acetylcholin esterase, and is used for improving the memory of a patient suffering from dementia and Alzheimer's disease. The invention also relates to a preparation method of the compound and an application in preparation of a drug for treating Senile Dementia.
Owner:SHIJIAZHUANG UNIVERSITY

5,7-diphenyl-5H-thiazolo[3,2-a]pyrimidine-2-carboxamide derivatives and application

The invention discloses 3-methyl-5,7-diphenyl-5H-thiazolo[3,2-a]pyrimidine-2-carboxamide derivatives shown in a formula I, or pharmaceutically acceptable hydrates or salts of the derivatives, i.e., stereoisomers or tautomers of the derivatives, wherein R1 and R2 in the formula I are respectively hydrogen, methyl, halogen, hydroxyl, methoxyl, acetyl, propionyl, nitro or alkoxy independently; R3 and R4 are independently selected from C1-C6 alkyl, or R3 and R4 form pyrrolyl, piperidinyl, morpholinyl, N-methylpiperazine and N-(4-bromophenyl piperazine) together with nitrogen atoms which are connected with the R3 and the R4. As vascular endothelial growth factor receptor tyrosine kinase inhibitors, the 3-methyl-5,7-diphenyl-5H-thiazolo [3,2-a]pyrimidine-2-carboxamide derivatives can be used for treating and preventing various cancers. The formula I is shown in the description.
Owner:SHIJIAZHUANG UNIVERSITY

5, 7-diphenyl-5H-thiazole [3, 2-a] pyrimidine-3-acetamide derivatives and application

The invention discloses 5, 7-diphenyl-5H-thiazole [3, 2-a] pyrimidine-3-acetamide derivatives of ageneral formula I described in the application or their hydrates and salts, including their stereoisomers or tautomers acceptable by pharmacy, wherein R1 and R2 informula I are independently hydrogen or methyl or halogen or hydroxyl or methoxy or acetyl orpropionyl or nitro or alkoxy; R3 and R4 are independently selected from the alkyl of C1-C6, or R3 and R4 together with the nitrogen atoms whichR3 and R4 are connected to build up pyrryl, piperidyl, morpholine, N-methyl piperazine, and N-(4-brominephenylpiperazine).The 5, 7-diphenyl-5H-thiazole and [3, 2-a] pyrimidine-3-acetamide derivatives are used as inhibitors of vascular endothelial growth factor receptor neuraminidase for the treatment and prevention of various cancers.
Owner:河北戴桥医药科技有限公司

Thiazole triazole-6-acetamide derivative and application

The invention discloses a thiazole [3,2-b] [1,2,4]-triazole-6-acetamide derivative as shown in formula I or a pharmaceutically acceptable hydrate and salt thereof. The derivative comprises a stereisomer or tautomer thereof; R1 in the formula I is hydrogen, methyl, halogen, hydroxy, methoxy group, acetyl, propionyl, nitro or alkoxy; R2 and R3 are independently selected from C1-C6 alkyl or R2 and R3 and nitrogen atoms connected with the R2 and R3 are formed into pyrryl, piperidyl, morpholinyl, N-methyl piperazine and N-phenylpiperazine. The thiazole [3,2-b] [1,2,4]-triazole-6-acetamide derivative disclosed by the invention has an obvious restraining function to acetylcholin esterase and is used for enhancing the memory of the patients suffering from dementia and Alzheimer's disease. The invention also relates to a preparation method of the compound and application of the compound for preparing the drug for treating the senile dementia.
Owner:SHIJIAZHUANG POLEE PHARMA CO LTD

Benzoyl substituted thiazolo[3,2-b]-1,2,4-triazine derivative and application thereof

The invention belongs to the field of medical technology, and relates to a benzoyl substituted thiazolo[3,2-b]-1,2,4-triazine derivative and an application thereof. The benzoyl substituted thiazolo[3,2-b]-1,2,4-triazine derivative comprises a stereoisomer and pharmaceutically acceptable salt of the benzoyl substituted thiazolo[3,2-b]-1,2,4-triazine derivative, wherein the structural general formula is shown in the specification; and the benzoyl substituted thiazolo[3,2-b]-1,2,4-triazine derivative and the pharmaceutically acceptable acid-added salt of the compound can be combined with the existing medicine or independently used as an acetylcholin esterase inhibitor and used for improving the memory of the patients suffering from dementia and Alzheimer disease. Compared with the existing Chinese patent, the 6-site side chain of thiazolo[3,2-b]-1,2,4-triazine is obviously changed, and the inhibition ratio of a sample against acetylcholin esterase is obviously improved.
Owner:SHENYANG PHARMA UNIVERSITY

2H-thiazolo [3, 2-b]-1, 2, 4-triazine-3, 7-diketone derivative and application thereof

The invention discloses a 2Hthiazolo [3, 2b] 1, 2, 4triazine 3, 7diketone derivative as shown in a general formula I or pharmaceutically acceptable hydrate and salt thereof, the 2Hthiazolo [3, 2b] 1,2, 4triazine 3, 7diketone derivative comprises stereoisomers or tautomers thereof, and R1 and R2 in the general formula I can be optionally selected from one, two or three independently selected fromhydrogen, alkyl, alkoxy, halogen, hydroxyl, acetyl, propionyl, nitro or trifluoromethyl. The 1, 2, 4-triazine 3, 7diketone derivative has an obvious inhibiting effect on acetylcholin esterase, and isused for enhancing the memory of a patient suffering from dementia and Alzheimer's disease. The invention also relates to a preparation method of the compound and the application of the compound in preparation of drugs for treating Alzheimer's disease.
Owner:SHIJIAZHUANG UNIVERSITY

2-phenyl-6-benzoyl-thiazolo[3,2-b][1,2,4]-triazole derivative and application thereof

The invention discloses a 2-phenyl-6-benzoyl-thiazolo[3,2-b][1,2,4]-triazole derivative disclosed as General Formula I or pharmaceutically acceptable hydrates and salts thereof, including stereomer or tautomers of the 2-phenyl-6-benzoyl-thiazolo[3,2-b][1,2,4]-triazole derivative. In the Formula I, R1 and R2 are respectively and independently hydrogen, methyl group, halogen, hydroxy group, methoxy group, acetyl group, propionyl group, nitro group or alkoxy group. The 2-phenyl-6-benzoyl-thiazolo[3,2-b][1,2,4]-triazole derivative has an obvious inhibiting action on acetylcholinesterase, and is used for enhancing memory of patients with dementia and Alzheimer's disease. The invention also discloses a preparation method of the compounds and application of the compounds in preparing drugs for treating senile dementia.
Owner:SHIJIAZHUANG UNIVERSITY

Benzoimidazole compound containing amide and application thereof

The invention belongs to the technical field of medicine, and relates to a 2-[(pyridin-2-yl-methyl)thio]-1H-benzimidazole compound and a preparation method and application thereof. The formula of the2-[(pyridin-2-yl-methyl)thio]-1H-benzimidazole compound and a pharmaceutically acceptable salt is as follows: R1 and R2 are the same or different, and are selected from hydrogen, C1-C8 alkyl, C3-C6 cycloalkyl, phenyl, halogen substituted phenyl, C1-C4 alkyl substituted phenyl, C1-C4 alkoxy substituted phenyl, halogen and C1-C4 alkyl simultaneously substituted phenyl, halogen and C1-C4 alkoxy simultaneously substituted phenyl, halogen-substituted C1-C4 alkyl substituted phenyl, benzyl, and 4-benzyloxyphenyl; or R1, R2 and the nitrogen atom connected with them constitutes a substituted or un-substituted morpholinyl, phenylpiperazine or diphenylmethylpiperazine; the substituent is C1-C4 alkoxy, C1-C4 alkyl and halogen; and R3 and R5 can be selected from hydrogen and C1-C4 alkyl. The compoundhas a simple synthesis method, is suitable for industrialized production, and has obvious anti-tumor activity.
Owner:SHENYANG PHARMA UNIVERSITY

Ureido-containing benzoimidazole compounds and application thereof

ActiveCN110003177ANovel structure typeGood prospects for development and applicationOrganic active ingredientsOrganic chemistryDrugBenzimidazole
The invention belongs to the technical field of medicines, and relates to ureido-containing benzoimidazole compounds, a preparation method thereof, and an application of the ureido-containing benzoimidazole compounds in preparing medicines for anti-tumor diseases. The structural general formula of the ureido-containing benzimidazole compounds, and precursor drugs, pharmaceutical active metabolitesand pharmaceutically acceptable salts thereof is shown as the follows, wherein R can be selected from hydrogen, phenyl, 4-chlorophenyl, 4-methylphenyl and 3-(trifluoromethyl)phenyl, and R<3> and R<5>can be selected from hydrogen and methyl. The compounds disclosed by the invention are simple and convenient in synthesis method and are suitable for industrial production. A biological activity testshows that the compounds have anti-tumor activity and are novel antitumor medicines.
Owner:SHENYANG PHARMA UNIVERSITY

Hederagenin polyethylene glycol derivative and preparation method thereof

The invention relates to the field of organic synthesis and medicinal chemistry, in particular to a hederagenin polyethylene glycol derivative with a novel structure and a preparation method of the hederagenin polyethylene glycol derivative. The compound disclosed by the invention is novel in structural type, improved in water solubility and excellent in tumor drug resistance reversion activity. The invention further provides a pharmaceutical composition for treating oral epithelial cancer, gastric cancer, lung cancer, cervical cancer, breast cancer or colon cancer and the like by being combined with clinically common anti-tumor drugs.
Owner:YANTAI UNIV

Indole-3-carboxamide compounds and their applications

The invention belongs to the technical field of medicine, and relates to indole-3-carboxamide compounds and applications thereof. The general structural formula of described indole-3-carboxamide compound is as follows: wherein, R 1 , R 2 , R 3 , R as described in the claims and description. The indole-3-carboxamide compounds of the present invention and the pharmaceutically applicable acid addition salts of such compounds can be used as antioxidants for the preparation of drugs for the treatment or prevention of diseases related to protein oxidative damage, and protein oxidative damage The related diseases caused are Alzheimer's disease, Parkinson's disease, diabetes and chronic renal failure.
Owner:SHENYANG PHARMA UNIVERSITY

Hedera saponin polyethylene glycol derivative and preparation method thereof

The invention relates to the fields of organic synthesis and medicinal chemistry, in particular to a helexin polyethylene glycol derivative with a novel structure and a preparation method thereof. The compound of the present invention has a novel structure type, improved water solubility, and excellent tumor drug resistance reversing activity, and further provides a compound used in combination with clinically used antineoplastic drugs for the treatment of oral epithelial cancer, gastric cancer, lung cancer, cervical cancer, breast cancer or colon cancer. Pharmaceutical composition for cancer etc.
Owner:YANTAI UNIV

Application of hedera saponin polyethylene glycol derivatives

The invention discloses the application of helexin polyethylene glycol derivatives. Specifically, the application of the helexin polyethylene glycol derivatives of the present invention in the preparation of tumor drug resistance reversal agents, and the novel structural type helexin polyethylene glycol derivatives provided by the present invention have improved water solubility, have Excellent tumor resistance reversing activity. The helexin polyethylene glycol derivative and a pharmaceutically acceptable carrier are used in combination with clinical antitumor drugs to treat diseases or conditions such as oral epithelial cancer, gastric cancer, lung cancer, cervical cancer, breast cancer or colon cancer. The use of the helexin polyethylene glycol derivative and the medically acceptable salt thereof of the present invention is used for preparing a tumor resistance reversal agent and / or a pharmaceutically acceptable carrier for treating mammals, preferably treating human diseases or diseases.
Owner:YANTAI UNIV

2‑Phenyl‑6‑benzoyl‑thiazolo[3,2‑b][1,2,4]‑triazole derivatives and their applications

The invention discloses 2-phenyl-6-benzoyl-thiazolo[3,2-b][1,2,4]-triazole derivatives of general formula I or pharmaceutically acceptable hydrates thereof , salts, including stereoisomers or tautomers thereof, R1 and R2 in formula I are independently hydrogen, methyl, halogen, hydroxyl, methoxy, acetyl, propionyl, nitro or alkane Oxygen. The 2-phenyl-6-benzoyl-thiazolo[3,2-b][1,2,4]-triazole derivatives of the present invention have obvious inhibitory effect on acetylcholinesterase, and are used to enhance Memory in patients with dementia and Alzheimer's disease. The invention also relates to a preparation method of the compound and its application in the preparation of a medicine for treating senile dementia.
Owner:SHIJIAZHUANG UNIVERSITY

5,7-Diphenyl-5h-thiazolo[3,2-a]pyrimidine-2-carboxamide derivatives and their applications

The invention discloses 3-methyl-5,7-diphenyl-5H-thiazolo[3,2-a]pyrimidine-2-carboxamide derivatives shown in a formula I, or pharmaceutically acceptable hydrates or salts of the derivatives, i.e., stereoisomers or tautomers of the derivatives, wherein R1 and R2 in the formula I are respectively hydrogen, methyl, halogen, hydroxyl, methoxyl, acetyl, propionyl, nitro or alkoxy independently; R3 and R4 are independently selected from C1-C6 alkyl, or R3 and R4 form pyrrolyl, piperidinyl, morpholinyl, N-methylpiperazine and N-(4-bromophenyl piperazine) together with nitrogen atoms which are connected with the R3 and the R4. As vascular endothelial growth factor receptor tyrosine kinase inhibitors, the 3-methyl-5,7-diphenyl-5H-thiazolo [3,2-a]pyrimidine-2-carboxamide derivatives can be used for treating and preventing various cancers. The formula I is shown in the description.
Owner:SHIJIAZHUANG UNIVERSITY

Thiazolotriazole-6-acetamide derivatives and their application

The invention discloses a thiazole [3,2-b] [1,2,4]-triazole-6-acetamide derivative as shown in formula I or a pharmaceutically acceptable hydrate and salt thereof. The derivative comprises a stereisomer or tautomer thereof; R1 in the formula I is hydrogen, methyl, halogen, hydroxy, methoxy group, acetyl, propionyl, nitro or alkoxy; R2 and R3 are independently selected from C1-C6 alkyl or R2 and R3 and nitrogen atoms connected with the R2 and R3 are formed into pyrryl, piperidyl, morpholinyl, N-methyl piperazine and N-phenylpiperazine. The thiazole [3,2-b] [1,2,4]-triazole-6-acetamide derivative disclosed by the invention has an obvious restraining function to acetylcholin esterase and is used for enhancing the memory of the patients suffering from dementia and Alzheimer's disease. The invention also relates to a preparation method of the compound and application of the compound for preparing the drug for treating the senile dementia.
Owner:SHIJIAZHUANG POLEE PHARMA CO LTD

Compound with PPAR delta agonistic activity, pharmaceutical composition and medical application

The invention discloses a compound with PPAR delta agonistic activity, a pharmaceutical composition and medical application, wherein the structure of the compound is shown as a formula I in the specification. The compound shown in the formula I is a novel PPAR delta agonist, so that the compound can be used for preparing medicines for preventing or treating PPAR delta mediated diseases.
Owner:CHINA PHARM UNIV

Benzimidazole compounds containing ureido group and application

The invention belongs to the technical field of medicine, and relates to a benzimidazole compound containing a ureido group, a preparation method thereof and an application in preparation of anti-tumor disease medicines. The general structural formula of the described benzimidazole compound containing ureido group, its prodrug and pharmaceutically active metabolite and pharmaceutically acceptable salt is as follows: R can be selected from hydrogen, phenyl, 4-chlorobenzene Base, 4-methylphenyl, 3-(trifluoromethyl)phenyl. R 3 , R 5 Can be selected from hydrogen, methyl. The synthesis method of the compound of the present invention is simple and convenient, and is suitable for industrial production. Biological activity tests show that the compound has antitumor activity, and is a new type of antitumor drug.
Owner:SHENYANG PHARMA UNIVERSITY

5-[2-Hydroxy-3-(isopropylamino)propoxy]benzofuran derivatives and their application

The invention belongs to the technical field of medicines, and relates to 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran derivatives and an application thereof. The 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran derivatives comprise stereoisomers and pharmaceutically acceptable salts of 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran, and the structural formula of the derivatives is shownin the description. The 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran derivatives and the pharmaceutically acceptable acid addition formed salts of 5-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran can be used together with existing medicines or individually, and are used for preparing medicines for treating blood vessel smooth muscle spasm diseases.
Owner:SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products